• / Free eNewsletters & Magazine
  • / My Account
Home>G-7

G-7

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis, Bayer - Research and Markets

    Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis, Bayer - Research and Markets

  2. Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 - Research and Markets

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016 - Research and Markets

  3. Has Quantitative Easing Given Labor Markets a Bump?

    Last year, G7 nations that implemented aggressive QE programs saw their unemployment rates drop by more than 1%, while those that didn't saw their rates increase or stay the same.

  4. Taking a Strategic Approach to Currency Exposure

    A surging dollar aside, think risk first when it comes to currency exposure.

  5. Taking a Strategic Approach to Currency Exposure

    A surging dollar aside, think risk first when it comes to currency exposure.

  6. Taking a Strategic Approach to Currency Exposure

    A surging dollar aside, think risk first when it comes to currency exposure.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.